HLB Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - HLB Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 7 250 KRW -4.98%

Market Cap: ₩237.8B

H	HLB Pharmaceutical Co Ltd KOSDAQ:047920	KR
	Beyondspring Inc NASDAQ:BYSI	US
V	Valmont Industries Inc SWB:VI1	US

Profitability Summary

HLB Pharmaceutical Co Ltd's profitability score is 43/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

46%

Strong 3Y Average Gross Margin

58%

Declining Gross Margin

63% > 46%

Low Operating Margin

Negative 3Y Average Operating Margin

-4%

Operating Margin is Increasing

-9% > 1%

Low Net Margin

Negative 3Y Average Net Margin

-3%

Net Margin is Increasing

-18% > 1%

Negative Free Cash Flow Margin

-2%

Negative 3Y Average Free Cash Flow Margin

-5%

Free Cash Flow Margin is Increasing

-10% > -2%

Low ROE

Negative 3Y Average ROE

Negative 3Y Average ROIC

-5%

ROIC is Increasing

-10% > 1%

View All

Hide

Collapse

43 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.